1. LDL-C-mockup-3

LDL-C-mockup-3

Hypercholesterolemia Educational Material
 
Duration : 05 min 03 sec
Cardiovascular Risk Factor Management: A Medical Expert's Perspective
Clin. Assoc. Prof. Tan Ru San
Senior Consultant Cardiologist National Heart Centre, Singapore (NHCS)
 
In case of any inquiries click here
In case of any inquiries click here
Cholesterol Disease Awareness Material
Learn more & download ASCVD educational material click here
x

Terms of Authorization to Use the Material

Novartis (Singapore) Pte Ltd (hereinafter referred to as "Novartis") is the copyright owner of this material (hereinafter referred to as the "Material"). Please read and accept the terms of this agreement before using the Material. Your use of the Material shall be deemed to have read, understood and agreed to be bound by this Agreement.
  1. The Material can be used on social media under your professional capacity (including but not limited to LinkedIn, Facebook, etc. of the hospital or clinics) strictly limited for disease awareness purpose only.
  2. The Material cannot be modified, adapted, translated or compiled with other materials.
  3. You, as a medical practitioner, have full editorial right with regards to the content on the social media accompanied by the Material, in compliance with applicable regulations, T&C of the social media platforms and industry code.
  4. The Material can only be used by the medical practitioner who are registered with MedHub (medhub.novartis.com.sg) and cannot be used by anyone else or sublicensed.
  5. Novartis reserves the right to request to make corrections, remove the posts using the Material or withdraw this authorization to use at any time at its sole discretion.
  6. Novartis does not authorize you to publish any content or remarks on behalf of Novartis. Novartis has no liability whatsoever for your use or modification of the Licensed Works.
  7. Any content you publish using the Material only represents your own views. You do not intend and will not express or imply that you publish any content or remarks on behalf of Novartis, and you should avoid any content that is misconstrued as being posted on behalf of Novartis or at the direction of Novartis.
  8. Novartis may update these terms of authorization at any time without prior notice at its sole discretion.
Agree to download Cancel
Hypercholesterolemia Webinar
Below you can access recordings from educational webinars hosted by experts in the field of ASCVD and organised by Novartis.

 

 
Inclisiran: emerging evidence for strategies to reach LDL-C targets
At the occasion of this year’s Congress of the European Atherosclerosis Society (EAS), Mannheim, Germany, we are excited to share with you a recording of this session which includes a discussion among our panel of experts, chaired by Prof Ulf Landmesser, Chair, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Benjamin Franklin, Deutsches Herzzentrum der Charite, Berlin, Germany. The session took place on Monday, May 22, 2023.
Prof Ulf Landmesser
Chair, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Benjamin Franklin, Deutsches Herzzentrum der Charite, Berlin, Germany
Prof Kausik Ray
Professor of Public Health and Honorary Cardiologist at Imperial College London and President of the European Atherosclerosis Society, UK
Prof Scott R Wright
Consultant, Division of Structural Heart Disease, Department of Cardiovascular Medicine, USA

 

View more videos...
 

Beyond the data: What drives clinical decisions for LDL-C management?

At the occasion of this year’s 90th Congress of the European Atherosclerosis Society (EAS), Milan, Italy, we are excited to share with you a recording of the session, chaired by Dr. Michal Vrablík, Charles University, Czech Republic. The session took place on Monday, May 23, 2022.

Michal Vrablik, MD, PhD
1st Faculty of Medicine, General University Hospital and Charles University, Czech Republic

Ingo Hilgendorf, MD
University Heart Center, Germany

Matthew Willcox
The Business of Choice LLC, United States

 

LIPIDS live – Fact or Fiction: Gaining Control over Cumulative LDL-C is Vital

Chair: Clinical A/Prof Yeo Khung Keong, National Heart Centre Singapore Speaker: Prof. Dr. Brian A Ference, The University of Cambridge, United Kingdom

LIPIDS live - ASCVD 2021: Current Challenges and Unmet Needs

Chair: A/ Prof Kian Keong Poh, National University Heart Centre Singapore Speaker: Prof. Kausik Ray

EAS Congress 2023
 
Inclisiran emerging evidence for strategies to reach LDL-C targets (Teaser video)
Rate this content: 
0
No votes yet
FA-11285296, SG2309108667, SG2305116578, SG2309056273, SG2309056270, SG2309172283
Print
×

Medical Information Request

×

Ask Speakers